Directorate Change
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your OPTI notes
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare, announces that Graham Myers has been appointed as Finance Director of the Company as of 1 December 2023.
Graham is a member of the Institute of Chartered Accountants in England & Wales and has extensive financial and commercial experience in a number of private and public companies, including being a member of the Executive Committee at Croda International Plc, where he worked for almost 30 years. Graham brings extensive experience in optimising financial controls, managing budgets, building profitable businesses and mergers & acquisitions. Graham is currently Chair of Croda Pension Trustees Limited, the sole trustee of Croda's £800m UK pension scheme.
Graham's appointment to this part-time role will see him work closely with the OptiBiotix team to support the focus on driving each business unit and the Group to profitability.
Pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies, the following information is disclosed in respect of Graham Lloyd Myers (aged 60):
| Current Directorships | Previous Directorships held in the past five years |
| Croda Pension Trustees Limited | Bio Futures PI Limited |
| Croda Trustees Limited | Cargill Bioindustrial BV (Previously Croda Nederland BV) |
Cowick Insurance Services Limited
Croda (Thailand) Co Ltd
Croda Cosmetics & Toiletries Limited
Croda Food Services Limited
Croda India Company Private Limited
Croda Investments Limited
Croda Investments No 2 Limited
Croda Investments No 3 Limited
Croda Overseas Holdings Limited
Croda Polymers International Limited
Croda World Traders Limited
Enza Biotech AB
Lanxess Urethanes UK Ltd
I. Bioscience Limited
Plant Impact Limited
Croda Indonesia LLC
Uniqema Limited
Uniqema UK Limited
Graham Myers holds no ordinary shares, options or warrants over ordinary shares in the Company.
There is no further information regarding Graham Myers required to be disclosed under the AIM Rules.
Stephen OHara, CEO of OptiBiotix commented: "We are pleased to confirm the appointment of Graham Myers as Finance Director. The appointment reflects the progress we have made in 2023 after a difficult 2022 and the Board's focus on controlling costs and building revenues to create a profitable international business with well-known global brands".
Caution regarding forward looking statements
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.